Availability predictions by hepatic elimination models for Michaelis-Menten kinetics.

Area of Science:

• Pharmacokinetics
• Biomedical Engineering
• Computational Biology

Background:

• Hepatic elimination models are crucial for predicting drug bioavailability.
• Michaelis-Menten kinetics describes enzyme saturation, a common factor in drug metabolism.
• Understanding variations in drug residence time within the liver is key to accurate bioavailability predictions.

Purpose of the Study:

• To compare the predictive accuracy of different hepatic elimination models.
• To evaluate model performance under Michaelis-Menten kinetics using propranolol and galactose.
• To identify key factors influencing drug availability predictions in the liver.

Main Methods:

• Numerical simulations were employed to compare various hepatic elimination models.
• Propranolol and galactose served as model compounds to test the models.
• Model predictions were analyzed across a range of concentrations, considering blood flow and protein binding.

Main Results:

• The dispersion model consistently predicted lower drug availability compared to segregated distribution models.
• Significant differences in predictions were observed for models with high variability in solute residence times.
• Tank-in-series and dispersion models with different boundary conditions showed similar predictions.
• Blood flow and protein binding had minimal impact on discriminating between model predictions.

Conclusions:

• Micromixing of blood within liver sinusoids significantly impacts drug availability.
• The anatomical location of mixing is a critical determinant of bioavailability when enzymes are saturated.
• Model selection is crucial for accurately predicting drug behavior during hepatic elimination.